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SYNOPSIS 
This cross-sectional comparison of Goldmann and Octopus perimetry, in 30 children aged 
5-15 years with neuro-ophthalmic disease, shows children ≥8 years can perform either test 
well but differences in outputs mean they are not interchangeable.  
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ABSTRACT 
Aims: We compared feasibility, quality and outcomes of visual field (VF) testing in children 
with neuro-ophthalmic disease, between the discontinued “gold-standard” Goldmann and 
Octopus perimeters. 
Methods: Children with neuro-ophthalmic disease, attending Great Ormond Street 
Hospital, London, were assessed using standardised protocols by one examiner in a single 
sitting, using Goldmann and Octopus kinetic perimetry. Outputs were classified to compare 
severity of loss and defect type. Test quality was assessed using both qualitative and 
quantitative methods. 
Results: Thirty children (40% female) aged 5-15 years participated. Goldmann perimetry 
was completed in full by 90.0% versus 72.4% for Octopus. Inability to plot the blind spot 
was the commonest reason for not completing testing. Over 75% completed a test in ≤20 
minutes. Duration was similar between perimeters (paired t-test, mean difference: 0.48 
minutes [-1.2, 2.2], p=0.559). The lowest quality tests were for Octopus perimetry in 
children <8 years, without significant differences between perimeters in older children 
(McNemar’s test, χ2=1.0, p=0.317). 
There was broad agreement between Goldmann and Octopus outputs (good quality, n=21, 
Bland-Altman, mean difference for isopters I4e (-514.3 deg2 [-817.4, -211.2], p=0.814), I2e (-
575.5 deg2 [-900.1, -250.9], p=0.450) and blind spot (20.8 deg2 [5.7, 35.8], p=0.451). 
However, VF severity grades and defect type matched in only 57% and 69% of tests 
respectively. Octopus perimetry under-estimated severe VF defects. 
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Conclusions: Informative perimetry is feasible in children ≥8 years with neuro-ophthalmic 
conditions, with either Goldmann or Octopus perimeters. However, meaningful differences 
exist between the two approaches with implications for consistency in longitudinal 
assessments.  
5 
 
INTRODUCTION 
Neurological conditions in children can compromise the visual pathways and result in visual 
field (VF) changes with/without reduced visual acuity (VA) and/or impaired colour vision.1 
There remains an incomplete evidence base regarding perimetry in the neuro-
ophthalmological evaluation of children,2 reflecting the challenges of performing an 
intensive task, requiring prolonged, steady fixation and prompt responses. In children 
without ophthalmic conditions, variations exist by approach in the minimum age for 
reliable testing and ability to detect specific defects.3-11 Commonly, children with neuro-
ophthalmic disease are assessed with kinetic perimetry to assess the full field, changes in 
VF shape/area, and delineate quadrant/hemi-field defects whereas static perimetry has 
limited ability to detect subtle but important neuro-ophthalmic changes such as mild 
peripheral loss, slight nasal steps or subtle blind spot defects. 
Goldmann perimetry is the established kinetic approach in children, but these perimeters 
are no longer commercially available.12 Proposed replacements (by Takagi and Inami) lack 
evidence to inform their use. However, Octopus perimeters are increasingly used in 
practice, adopting ‘Goldmann equivalent’ stimuli for kinetic perimetry, automated stimuli 
presentation, and drawing on normative data for interpreting outputs in children.13  
To improve the evidence base for clinicians making decisions about perimetry in children 
with neuro-ophthalmic disease, we investigated differences between Goldmann and 
Octopus kinetic perimetry in the context of a wider research programme (the OPTIC study), 
by comparing feasibility, quality and outputs.  
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METHODS 
We embedded this cross-sectional study within routine clinical care in our neuro-
ophthalmology service at Great Ormond Street Hospital. Children aged 5 to 15 years, with 
either a diagnosed neuro-ophthalmic condition or known neuro-ophthalmic VF defect1 
were included to capture this heterogeneous population. For ethical and data quality 
considerations, children unable to perform perimetry, because they were systemically 
unwell or unable to comprehend or co-operate for other reasons were not included. 
Potential participants were identified by examining medical records and were approached 
during their scheduled hospital visit. Children and their parents were given information 
sheets and opportunities to ask questions about the study. Parents/guardians gave formal 
written consent, whilst children gave verbal assent. 
Visual fields were measured using a Goldmann perimeter (Haag-Streit, Bern, Switzerland) 
and Octopus 900 (Haag-Streit), in a darkened clinic room, both by a single experienced 
Orthoptist, who was unmasked to the participants’ VF defect but had not previously tested 
them. 
To prioritise continuity of care, test order was not randomised. Thus Goldmann perimetry 
was performed first, followed by a 5-minute rest period before Octopus perimetry. The 
right eye was assessed first unless contra-indicated clinically. Before each test participants 
were given standardised age-appropriate instructions regarding fixation and responding to 
stimuli, and tested their buzzer.14 After occlusion of one eye using a soft eye pad, they were 
aligned at the perimeter whilst sitting on a height adjustable chair. 
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Preparation time and any modifications necessary were recorded. Encouragement and 
repetition of instructions were given throughout. Rest breaks were offered and recorded if 
taken. 
Refractive errors were corrected for isopter I2e only,15 if greater than +3.00 dioptre spheres 
(DS), greater than -1.00DS, or greater than 1.00 dioptre cylinder. Where applicable, choice 
of isopters was based on previous Goldmann perimetry, with identical isopters selected for 
Octopus perimetry. Participants without prior experience were assessed using isopters I4e 
and I2e. All tests started with plotting an outer, followed by inner isopter and then blind 
spot (I2e, stimulus speed of 2/sec), allowing accustomisation with easier stimuli. 
Targets were presented along 12 cardinal meridia (every 30, at 5/sec (automated for 
Octopus, approximated for Goldmann)), centripetally from a non-seeing area (manually 
defined start points), followed by further points, up to a maximum of 24 (i.e. every 15°). For 
children with hemianopia, targets were presented centripetally for the seeing half of the 
field, but were presented every 15° along the y-axis, from non-seeing to seeing areas, for 
the non-seeing field. 
Quality of each test was assessed using the Examiner Based Assessment of Reliability 
(EBAR),14 which standardises the conventional qualitative clinical approach, taking account 
of comprehension of instructions, co-operation, fatigue, fixation and response to stimuli, to 
rate assessments as either ‘good’, ‘fair’ or ‘poor’ quality (eTable 1). We applied the 
quantitative Kinetic Perimetry Reliability Measure (KPRM)16 of test-retest variability that 
uses the median value of the differences between 4 paired measurements: lower scores 
indicate better quality. Finally, children rated each test, using a 5-point Likert scale ranging 
from ‘very hard’ to ‘very easy’ and any additional comments were recorded. 
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Goldmann VF plots were digitised using Engauge digitizer (open source, 
http://www.digitizer.sourceforge.net) and Goldmann and Octopus co-ordinates were 
extracted into matrices using the kineticF package17 in R (The R Project for Statistical 
Computing; version 3.2.0, http://www.r-project.org). VF defects were graded by the same 
unmasked clinician, using the adaptation of Wall and George’s18 classification system for 
children, but retaining information on blind spot defects.19 Higher scores represent greater 
VF loss, from mild isopter constriction of less than 10° (Grade 1), to marked loss (Grade 5 – 
isopter V4e within 20°). Type of VF defect was categorised and compared.20 
The National Health Service Research Ethics Committee for London - Bloomsbury 
approved the study which followed the Declaration of Helsinki tenets. 
Statistical analysis 
Data were hosted securely in a Research Electronic Data Capture database21 at UCL GOS 
ICH and exported to STATA (StataCorp, version 12) for analysis. 
Analysis of feasibility draws on all participants. Statistical comparisons of outputs only use 
data from participants with ‘good EBAR’ scores for both tests i.e. tests deemed 
representative of a subject’s true VF sensitivity. Comparisons of test duration used paired t-
tests and agreement between isopter area from each perimeter was analysed by the Bland-
Altman method.22 Agreement between VF loss severity scores was measured with linearly 
weighted Kappa statistics (perfect agreement=1, with a decrease of 0.25 per level increase 
in disagreement).23 EBAR quality ratings were compared using McNemar’s test.24  
Multivariable linear regression models were fitted to investigate the relationship between 
test duration and age (continuous variable) including only factors significant at a 10% level 
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(2-sided, p<0 .1) in univariable analyses, such as VA, isopter area (I4e), sex and ethnicity. 
Logistic regression models were fitted to investigate the relationship between EBAR and 
KPRM. Robust variance estimates were used to account for within-subject correlation (2 
eyes).25 
RESULTS 
Thirty of 31 (96.8%) eligible children participated. The mean age of participants was 11.1 
years (SD: 2.6), 12 (40%) were females and 22 were White (73.3%), with 3 Black, 4 Asian and 
1 Mixed ethnicity child. 
Twenty participants had prior experience of VF testing ranging from 1 to 8 years’ 
experience (median = 2 years (IQR: 1-3.5)), with a median of 1.25 tests (IQR: 1-2.1) per year. 
Median VA and spherical equivalent (averaged within subject, n=30) was 0.04 LogMAR 
(IQR: -0.08, 0.21) and 0.0 dioptres (IQR: 0.0, 0.56), respectively. 
Table 1 lists, for all 30 participants, diagnosis, type of VF defect recorded by Goldmann, and 
agreement with Octopus, and grade of VF loss for Goldmann and Octopus perimetry. 
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Table 1. Neuro-ophthalmic diagnoses, associated visual field (VF) defects, and grade of VF loss for all 30 participants, ordered by increasing severity of VF loss 
Neuro-ophthalmic 
diagnosis 
Age 
(years) 
Eye Visual field defect* 
Matching type 
of VF defect?20 
Grade of visual field loss 
using the modified Wall 
and George system13 
Goldmann Octopus 
Idiopathic Intracranial 
Hypertension (IIH) 
7 
Right Normal visual field Yes 0 0 
Left Normal visual field Yes 0 0 
Suprasellar cyst. 
Hydrocephalus with VP 
shunt 
7 
Right Normal visual field Yes 0 0 
Left Normal visual field Yes 0 0 
Bilateral discrete white 
matter lesions 
7 
Right 
Normal visual field (previously found to have a 
nasal step) 
Yes 0 0 
Left 
Normal visual field (previously found to have a 
nasal step) 
Yes 0 0 
Pituitary stalk lesion 8 
Right Normal visual field Yes 0 0 
Left Normal visual field No 0 1 
Craniopharyngioma 
treated with cyst 
decompression and 
photon therapy 
14 
Right Normal visual field No 0 1 
Left Normal visual field No 0 1 
Langerhan’s cell 
histiocytosis with lesions 
in the base of skull and 
orbits 
12 
Right Normal visual field Yes 0 0 
Left Enlarged blind spot Yes 1 1 
Transverse myelitis with 7 Right Normal visual field No 0 3 
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optic neuritis and disc 
pallor  Left Mild reduction in central visual field sensitivity  Yes 1 2 
Acute Myeloid Leukaemia 
(AML) and BIH 
12 
Right Normal visual field Yes 0 0 
Left 
Mild isopter constriction, with enlargement of 
the blind spot 
No 1 0 
IIH 11 
Right Mild isopter constriction No 1 0 
Left Normal visual field Yes 0 0 
Suprasellar epidermoid 
cyst 
11 
Right Normal visual field Yes 0 0 
Left 
Small nasal step, with grossly enlarged blind 
spot 
Yes 2 2 
Craniopharyngioma 
treated with proton beam 
therapy 
9 
Right 
Mild reduction in central visual field 
sensitivity, with an enlarged blind spot 
Yes 1 1 
Left 
Mild reduction in central visual field 
sensitivity, with an enlarged blind spot 
Yes 1 1 
Craniopharyngioma 
(partially resected) 
9 
Right 
Mild reduction in central visual field 
sensitivity, with an enlarged blind spot 
Yes 1 1 
Left 
Mild reduction in central visual field 
sensitivity, with an enlarged blind spot 
Yes 1 1 
Left optic nerve glioma 12 
Right Enlarged blind spot Yes 1 3 
Left 
Mild isopter constriction, with an enlarged 
blind spot 
Yes 1 2 
IIH 13 Right Mild isopter constriction No 1 1 
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Left Mild isopter constriction No 1 1 
Secondary raised 
intracranial pressure (ICP) 
post steroids 
10 
Right Mild reduction in central visual field sensitivity N/A 1 N/A 
Left Mild isopter constriction (superior) N/A 1 N/A 
Papilloedema 5 
Right Mild reduction in central visual field sensitivity Yes 1 1 
Left Mild reduction in central visual field sensitivity N/A 1 N/A 
Pontine cavernoma 11 
Right Mild reduction in central visual field sensitivity No 1 0 
Left Mild reduction in central visual field sensitivity No 1 0 
Low grade glioma 13 
Right Enlarged blind spot No 1 0 
Left 
Mild reduction in central visual field 
sensitivity, with enlarged blind spot 
No 1 0 
IIH 14 
Right 
Moderate isopter constriction, with enlarged 
blind spot 
Yes 1 2 
Left 
Moderate isopter constriction, with enlarged 
blind spot 
Yes 2 2 
IIH 14 
Right 
Moderate reduction in central visual field 
sensitivity, with enlarged blind spot 
Yes 2 2 
Left 
Moderate reduction in central visual field 
sensitivity, with enlarged blind spot 
Yes 2 2 
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Right optic nerve glioma 8 
Right 
Moderate isopter constriction (nasal step), 
with an enlarged blind spot 
Yes 2 2 
Left Normal visual field No 0 1 
Chiari I malformation 10 
Right 
Moderate isopter constriction, with enlarged 
blind spot 
Yes 3 3 
Left 
Mild isopter constriction, with enlarged blind 
spot 
No 1 0 
Medulloblastoma 10 
Right 
Mild/moderate isopter constriction, with 
isopter I2e inside 20° 
Yes 2 2 
Left 
Moderate isopter constriction, with a nasal 
step 
Yes 3 2 
Pilocytic brainstem 
astrocytoma with a 
paramacular scar 
10 
Right 
Moderate isopter constriction, with isopter 
I2e inside 20° 
Yes 2 1 
Left 
Moderate isopter constriction, with isopter 
I2e inside 20° 
Yes 2 2 
Posterior fossa 
astrocytoma (resected) 
with a left 4th cranial 
nerve palsy 
9 
Right 
Moderate isopter constriction, with isopter 
I2e inside 10° 
No 3 1 
Left 
Moderate isopter constriction, with isopter 
I2e inside 20° 
No 2 1 
Arachnoid cyst – tilted 
discs with bilateral 
peripupillary atrophy 
9 
Right 
Moderate reduction in central visual field 
sensitivity, with isopter I2e inside 10° 
Yes 3 2 
Left 
Moderate reduction in central visual field 
sensitivity, with isopter I2e inside 10° 
Yes 3 2 
Grade I ganglioglioma 11 Right Moderate isopter constriction Yes 3 3 
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(left cerebellum). 
Posterior fossa 
craniotomy 
Left 
Moderate isopter constriction, with a right 
hemifield defect 
No 4 3 
Cervical meningocele 
with hydrocephalus and 
Chiari II malformation 
13 
Right Severe isopter constriction Yes 4 4 
Left Severe isopter constriction Yes 4 4 
Epilepsy (lobectomy) 15 
Right Right homonymous hemianopia Yes 4 4 
Left Right homonymous hemianopia Yes 4 4 
Glioma (Occipital lobe 
high grade) 
11 
Right Left homonymous hemianopia Yes 4 4 
Left Left homonymous hemianopia Yes 4 4 
* As recorded with Goldmann perimetry 
N.B. Shaded cells represent comparisons in those with good EBAR ratings for Goldmann and Octopus perimetry (n=42) 
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Feasibility of perimetry 
One subject completed only Goldmann perimetry before withdrawing. Two children 
required rest breaks during Goldmann perimetry and were subsequently unable to 
complete Octopus perimetry. 27/30 participants (90%) completed the Goldmann 
assessment in full, but in 3/30 (10%) the blind spot could not be plotted due to poor 
cooperation. 22/29 (75.9%) completed the Octopus assessment in full (Table 2), but in 5, 
the blind spot could not be plotted due to poor cooperation. In 1 of these children a KPRM 
could not be plotted and in another testing was terminated due to fatigue. In addition, 1 
child with Goldmann and 2 with Octopus perimetry had unreliable blind spot assessments. 
Thus, there were 4 (13%) and 7 (24%) either missing or unreliable blind spot plots for 
Goldmann and Octopus perimetry, respectively. Children with hemifield defects were 
noted to use intermittent search strategies to explore their non-seeing field. 
Test duration was similar for both tests (t-test, n=29, mean difference: 0.48 minutes, [-1.2, 
2.2], p=0.559), and did not vary with increasing age for either Goldmann (-0.02 
minutes/year [-0.50, 0.47], p=0.939) or Octopus perimetry (0.43 (-0.19, 1.04) minutes/year, 
p=0.164) (Table 2). Isopter area, VA, sex, and ethnicity were not associated with test 
duration for either perimeter (univariable analyses). 
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Table 2. Test feasibility and quality for Goldmann (n=30) and Octopus perimetry (n=29) 
Age group 
(years) 
Number completing 
assessments (%) 
Median test duration* (min) 
(IQR) 
Test quality** (EBAR rating) (%) 
Good Fair Poor 
Goldmann  Octopus  Goldmann  Octopus  Goldmann  Octopus  Goldmann  Octopus  Goldmann  Octopus  
5-7 
(n=5) 
4 (80) 3 (60) 16 (14, 17) 16 (15, 17) 4 (80) 2 (40) 1 (20) 1(20) 0 2 (40) 
8-11 
(n=15)*** 
14 (93.3) 10 (66.7) 18 (16, 19) 17 (15, 19) 13 (86.7) 13 (92.9) 2 (13.3) 1(7.1) 0 0 
12-15 
(n=10) 
9 (90) 9 (90) 17.5 (16, 19) 18 (15, 19) 7 (70) 7 (70) 2 (20) 3 (30) 1(10) 0 
All ages 27/30 (90) 22/29 (75.9) 17 (16, 19) 17 (15, 19) 24/30 (80) 22/29 (75.9) 5/30 (16.7) 5/29 (17.2) 1/30 (3.3) 2/29 (6.9) 
*Test duration values include preparation and assessment tasks and include those children who failed to complete assessments 
**Test quality ratings include those who failed to complete assessments in full 
***n=14 for Octopus perimetry 
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Quality of perimetry 
Quality ratings are shown in Table 2 (Goldmann, n=30, Octopus, n=29). Failure to complete 
full testing was associated with poorer quality (i.e. not ‘good’ EBAR) in 3/3 (100%) children 
for Goldmann and 3/7 (43%) children for Octopus perimetry – reflecting, for Octopus 
perimetry, the small number of otherwise co-operative children in whom the blind spot 
could not be plotted. 
Test quality (EBAR) was similar for Goldmann and Octopus perimetry for children ≥8 years 
(McNemar’s test, χ2=1.0, p=0.317). Children under 8 years demonstrated better quality 
results with Goldmann (4/5, 80% good EBAR) than Octopus perimetry (2/5, 40% good 
EBAR). 
4/30 (13%) and 10/29 (34%) demonstrated fatigue during Goldmann and Octopus perimetry 
respectively. 7/29 (24%) children responded to the sound of stimulus presentation during 
Octopus perimetry, with 2/29 children (6.9%) sufficiently distracted to affect test quality. 
The KPRM was implemented in 57/58 (98%) eyes completing full testing. KPRM values 
increased (i.e. worsened) with poorer test quality for Goldmann (adjusted OR: 4.0 [2.1, 5.9], 
good vs. combined fair and poor quality), but not Octopus perimetry (1.4 [-0.7, 3.6], 
p=0.178) (Table 3).  
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Table 3. Median Kinetic Perimetry Reliability Measure (KPRM) values, by EBAR quality scores for 
Goldmann and Octopus kinetic perimetry in all participants 
EBAR rating 
Median KPRM (IQR) 
Goldmann Octopus 
Good 1.8 (1.2, 3.8) 2.7 (2.2, 4.3) 
Fair 7.4 (4.6, 9.1) 4.5 (3, 7.4) 
Poor 6.8 (5.4, 8.3)* N/A** 
* Values indicate data range 
** Those with poor quality Octopus results (n=2) were unable to plot a KPRM 
Test outputs 
Goldmann and Octopus VF loss severity scores showed broad agreement (=0.65 
(SE=0.10), n=21, good ‘EBAR’ only, Table 4). Scores were identical in 24/42 tests (57%) with 
11/18 (61.1%) non-identical scores being lower (i.e. less severe VF loss) for Octopus. All non-
identical tests scored ≥2 with Goldmann perimetry had a lower Octopus score but 
discordance was >1 in only 1/42 (2.4%) test. Goldmann and Octopus outputs matched with 
respect to type of field defect in 29/42 (69%) tests.  
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Table 4. Comparison of Goldmann and Octopus classification scores 
Goldmann 
classification 
score 
Octopus classification score 
Total eyes 
0 1 2 3 4 
0 9 4 0 0 0 13 
1 6 5 1 0 0 12 
2 0 2 7 0 0 9 
3 0 1 3 1 0 5 
4 0 0 0 1 2 3 
Total eyes 15 12 11 2 2 42 
* Shaded areas represent equivalent scores. N.B. Only participants who have ‘good’ EBAR scores on 
both tests are shown here (n=21) 
On average, Octopus outputs depicted more extensive fields (i.e. less VF loss); mean 
difference -514.3 deg2 [-817.4, -211.2] and -575.5 deg2 [-900.1, -250.9] for isopters I4e and 
I2e respectively. On average, using Goldmann, blind spot area was 20.8 deg2 [5.7, 35.8] 
larger. Bland-Altman analysis (eFigure 1A-C), showed modest agreement for the blind spot 
and smaller Goldmann area measures with both isopters, although limits of agreement 
were wide with increasing variation as average isopter area increased. 
Blind spot size (using Goldmann perimetry) was larger for those with classification scores ≥1 
compared to those with score 0 (Table 5).  
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Table 5. Blind spot size for classification scores of 0 or higher in participants with ‘good’ quality tests 
 
Goldmann classification score Octopus classification score 
Reference* 0 ≥1 Reference* 0 ≥1 
Median 
blind 
spot 
size 
(deg2) 
(IQR) 
76.4  
(61.4, 94.7) 
84.5 
(72.6, 94.3) 
113.6 
(86.2, 147.7) 
60.8  
(41.9, 80.6) 
79 
(68, 97.5) 
75.5 
(53.9, 135.5) 
* Reference values are based on age-appropriate normative data13 
Self-report of examination experience 
Only 2 children reported Goldmann perimetry to be ‘hard’. All other tests (n=57) were 
scored as ‘OK’ (Goldmann, n=11 (41%), Octopus, n=14 (52%)), ‘easy’ (Goldmann, n=7 (26%), 
Octopus, n=10 (37%)) or ‘very easy’ (Goldmann, n=7 (26%), Octopus, n=3 (11%)). Eight 
children preferred Octopus perimetry, citing newer/computerised technique, more 
reliable/different buzzer, more visible stimuli (n=3) and central fixation point (n=2), and 
more comfortable chinrest.  
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DISCUSSION 
We report a comparison of Goldmann and Octopus perimetry in children with diverse 
neuro-ophthalmic disorders, showing similar test duration for all ages, and similar quality in 
children over 8 years. Test quality did not improve with increasing age. Though both tests 
delineated neuro-ophthalmic VF defects, in many children neither the severity of VF loss 
nor type of defect depicted concorded between perimeters. Thus, although Goldmann and 
Octopus perimeters are similar in specification, their outputs are not directly 
interchangeable in this heterogeneous population. 
Our study sample intentionally excluded children in whom formal perimetry would be 
precluded. Children were under active clinical monitoring, necessitating capturing of 
Goldmann perimetry and precluding test order randomisation which potentially introduced 
bias through fatigue and/or learning effects. However, quality ratings were only better for 
the first test in children under 8 years of age and test completion rates followed similar 
trends to those previously reported in children without ophthalmic disease (90% vs. 96.1% 
for Goldmann and 75.9% vs. 89% for Octopus perimetry).14 A single examiner with 
expertise in perimetry undertook all the tests to avoid inter-examiner variability. This 
examiner was unmasked to the participants’ initial defect. Subsequent grading (as a 
separate exercise and without reviewing clinical details) of the recorded VF defects was also 
undertaken by one unmasked examiner using classification systems that do not include 
subjective interpretation. 
We used the EBAR14 and KPRM16 metrics, our recently developed standardised measures of 
kinetic perimetry quality. EBAR scores show good agreement with static automated 
indices14 and KPRM ratings allow quantifiable documentation of test-retest variability, and 
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thus aid interpretation of repeated testing over time. The ability to differentiate true 
change in VF sensitivity versus fluctuations in test quality is clinically significant: in the 
absence of automated reliability indices for kinetic perimetry, combined use of EBAR and 
KPRM scoring systems may help. 
Whilst complete agreement between Goldmann and Octopus perimetry regarding extent 
of VF loss may not be absolutely essential, our finding that Octopus perimetry may 
underestimate the most severe VF defects is important. Since differences between the two 
perimeters were also isopter-sensitive, it is not recommended to use perimeters 
interchangeably when monitoring children longitudinally. Thus, if replacing Goldmann with 
Octopus perimetry, clinicians will need to develop appropriate strategies to transition 
patients, and interpret findings against perimeter-specific normative values. Further 
research is required to increase knowledge about monitoring progression with Octopus 
perimetry. 
Inability to accurately plot blind spots was more common with Octopus perimetry even 
when far-peripheral testing was successful. Assessment of isolated blind spot defects can 
be of primary interest but also add nuanced interpretation of perimetry outputs. 
Participants were less affected by the noise of Octopus perimetry than reported previously 
by children without field defects (11% vs. 6.9%)14 and commonly preferred Octopus 
perimetry. However, preference for test modality is not necessarily associated with better 
test quality.14 Contrary to findings in normative populations15 and children with glaucoma,26 
test duration did not decrease with increasing age, possibly reflecting the challenges of 
assessing and characteristics of children with complex neurological conditions. 
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Our findings show the importance of stringent control of fixation, especially in patients with 
hemifield defects who have potential for recovery of field loss.27 Kinetic perimetry, pausing 
presentation of stimuli until fixation is restored, can improve accuracy of testing, mitigating 
fixation losses and search strategies. 
There are no previous studies of conventional kinetic perimetry in a heterogeneous 
population of children with all-cause neuro-ophthalmic disease against which we can 
compare directly our findings. Early identification of visual field loss is highly important but 
remains challenging in children in whom conventional perimetry is not possible, and for 
those too young to co-operate with testing. Attention needs to be directed to developing 
and refining approaches which allow early detection of gross defects including approaches 
that are showing promise in the evaluation of young children.28-30 Non-quantifiable, or 
supra-threshold tests have merit in this regard but are limited with respect to their ability to 
act as a ‘baseline’ assessment for monitoring progressive VF loss in those who can be 
expected to be able to perform full formal perimetry later in childhood. We suggest future 
research should be directed at identifying the elements of kinetic perimetry with greatest 
diagnostic value in specific conditions, to develop disorder-specific protocols that maximise 
utility whilst minimising burden of testing. Our generic findings should inform the design of 
such research. 
Static perimetry has poor sensitivity for detecting subtle peripheral neuro-ophthalmic 
defects.31 Large defects should be detectable by static perimetry, though limited evidence 
exists about the effect of algorithm ‘optimisation’ for glaucoma, and thus we suggest 
kinetic perimetry is preferable for neuro-ophthalmic defects of any severity.32 
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Our findings, in a heterogeneous group of children with neuro-ophthalmic disease able to 
co-operate with formal testing, support attempting either Octopus or Goldmann kinetic 
perimetry in children ≥8 years of age, with the expectation of meaningful outputs in most. 
However, clinicians should be mindful that outputs are not directly interchangeable, and 
that differences are greatest with the most severe visual field loss, with implications for 
transitioning from Goldmann to Octopus perimeters.   
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